2,099
Views
22
CrossRef citations to date
0
Altmetric
Original Research

TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer

, , , , , ORCID Icon, , , , ORCID Icon, , , , , , , , , , , , , , , & show all
Article: e1386826 | Received 20 Jun 2017, Accepted 26 Sep 2017, Published online: 19 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yang Yang, Md Sahidul Islam, Yuanjia Hu & Xin Chen. (2021) TNFR2: Role in Cancer Immunology and Immunotherapy. ImmunoTargets and Therapy 10, pages 103-122.
Read now
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now

Articles from other publishers (20)

Muhammad Abdullah, Amjed Ali, Muhammad Usman, Anam Naz, Javed Anver Qureshi, Majed A. Bajaber & Xiao Zhang. (2023) Post COVID-19 complications and follow up biomarkers. Nanoscale Advances 5:21, pages 5705-5716.
Crossref
Mengqian Chen, Gaojia Wang, Zhijian Xu, Jie Sun, Bo Liu, Lei Chang, Jianxin Gu, Yuanyuan Ruan, Xiaodong Gao & Shushu Song. (2023) Loss of RACK1 promotes glutamine addiction via activating AKT/mTOR/ASCT2 axis to facilitate tumor growth in gastric cancer. Cellular Oncology.
Crossref
Bo Li, Hui Chen, Shaohua Yang, Feng Chen, Liangliang Xu, Yan Li, Mingzhe Li, Chengming Zhu, Fangyuan Shao, Xinhua Zhang, Chuxia Deng, Leli Zeng, Yulong He & Changhua Zhang. (2023) Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers. Molecular Cancer 22:1.
Crossref
Takeshi Takasago, Ryohei Hayashi, Yoshitaka Ueno, Misa Ariyoshi, Kana Onishi, Ken Yamashita, Yuichi Hiyama, Hidehiko Takigawa, Ryo Yuge, Yuji Urabe, Shiro Oka, Yasuhiko Kitadai & Shinji Tanaka. (2023) Anti-tumor necrosis factor-alpha monoclonal antibody suppresses colorectal cancer growth in an orthotopic transplant mouse model. PLOS ONE 18:3, pages e0283822.
Crossref
Xingwu Liu, Guanyu Yan, Boyang Xu, Han Yu, Yue An & Mingjun Sun. (2022) Evaluating the role of IDO1 macrophages in immunotherapy using scRNA-seq and bulk-seq in colorectal cancer. Frontiers in Immunology 13.
Crossref
Clara Di Vito, Francesca Calcaterra, Nicolò Coianiz, Sara Terzoli, Antonio Voza, Joanna Mikulak, Silvia Della Bella & Domenico Mavilio. (2022) Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications. Frontiers in Immunology 13.
Crossref
Peng Song, Wenbin Li, Lei Guo, Jianming Ying, Shugeng Gao & Jie He. (2022) Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing. Frontiers in Immunology 13.
Crossref
Juliane Medler, Kirstin Kucka & Harald Wajant. (2022) Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy. Cancers 14:11, pages 2603.
Crossref
Muchun Li, Xiaozhen Zhang, Xueli Bai & Tingbo Liang. (2022) Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer. Frontiers in Oncology 12.
Crossref
M. Babul Islam, Utpala Nanda Chowdhury, Zulkar Nain, Shahadat Uddin, Mohammad Boshir Ahmed & Mohammad Ali Moni. (2021) Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes. Computers in Biology and Medicine 136, pages 104668.
Crossref
Allen Y. Chen, Jedd D. Wolchok & Anne R. Bass. (2021) TNF in the era of immune checkpoint inhibitors: friend or foe?. Nature Reviews Rheumatology 17:4, pages 213-223.
Crossref
Hamed Fouladseresht, Mehrnoosh Doroudchi, Najmeh Rokhtabnak, Hossein Abdolrahimzadehfard, Amir Roudgari, Golnar Sabetian & Shahram Paydar. (2021) Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19. Cytokine & Growth Factor Reviews 58, pages 32-48.
Crossref
Yushan Liu, Wenfen Fu, Wei Chen, Yuxiang Lin, Jie Zhang & Chuangui Song. (2021) Correlation of immune infiltration with clinical outcomes in breast cancer patients: The 25‐gene prognostic signatures model. Cancer Medicine 10:6, pages 2112-2124.
Crossref
Joshua N. Gustine & Dennis Jones. (2021) Immunopathology of Hyperinflammation in COVID-19. The American Journal of Pathology 191:1, pages 4-17.
Crossref
Alsamman M. Alsamman & Hatem Zayed. (2020) The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1. PLOS ONE 15:12, pages e0243270.
Crossref
Linzhi Han, Hongjie Shi, Yuan Luo, Wenjie Sun, Shuying Li, Nannan Zhang, Xueping Jiang, Yan Gong & Conghua Xie. (2020) Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma. Cancer Medicine 9:24, pages 9581-9594.
Crossref
Wei Zhou, Danni Lin, Zibiao Zhong & Qifa Ye. (2020) Roles of TRAFs in Ischemia-Reperfusion Injury. Frontiers in Cell and Developmental Biology 8.
Crossref
Jon Hazeldine & Janet M. Lord. (2020) Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?. Frontiers in Immunology 11.
Crossref
Nicolas Vabret, Graham J. Britton, Conor Gruber, Samarth Hegde, Joel Kim, Maria Kuksin, Rachel Levantovsky, Louise Malle, Alvaro Moreira, Matthew D. Park, Luisanna Pia, Emma Risson, Miriam Saffern, Bérengère Salomé, Myvizhi Esai Selvan, Matthew P. Spindler, Jessica Tan, Verena van der Heide, Jill K. Gregory, Konstantina Alexandropoulos, Nina Bhardwaj, Brian D. Brown, Benjamin Greenbaum, Zeynep H. Gümüş, Dirk Homann, Amir Horowitz, Alice O. Kamphorst, Maria A. Curotto de Lafaille, Saurabh Mehandru, Miriam Merad, Robert M. Samstein, Manasi Agrawal, Mark Aleynick, Meriem Belabed, Matthew Brown, Maria Casanova-Acebes, Jovani Catalan, Monica Centa, Andrew Charap, Andrew Chan, Steven T. Chen, Jonathan Chung, Cansu Cimen Bozkus, Evan Cody, Francesca Cossarini, Erica Dalla, Nicolas Fernandez, John Grout, Dan Fu Ruan, Pauline Hamon, Etienne Humblin, Divya Jha, Julia Kodysh, Andrew Leader, Matthew Lin, Katherine Lindblad, Daniel Lozano-Ojalvo, Gabrielle Lubitz, Assaf Magen, Zafar Mahmood, Gustavo Martinez-Delgado, Jaime Mateus-Tique, Elliot Meritt, Chang Moon, Justine Noel, Tim O’Donnell, Miyo Ota, Tamar Plitt, Venu Pothula, Jamie Redes, Ivan Reyes Torres, Mark Roberto, Alfonso R. Sanchez-Paulete, Joan Shang, Alessandra Soares Schanoski, Maria Suprun, Michelle Tran, Natalie Vaninov, C. Matthias Wilk, Julio Aguirre-Ghiso, Dusan Bogunovic, Judy Cho, Jeremiah Faith, Emilie Grasset, Peter Heeger, Ephraim Kenigsberg, Florian Krammer & Uri Laserson. (2020) Immunology of COVID-19: Current State of the Science. Immunity 52:6, pages 910-941.
Crossref
Zijun Wang, Yinhuai Wang, Mou Peng & Lu Yi. (2020) UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer. Frontiers in Oncology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.